Figures & data
Table 1. Clinical data of the patients.
Figure 1. Assessment of the left elbow psoriatic lesion treated with MTX microemulsion formulation only along the treatment course for patient 1: (A) before treatment, (B) after 3 weeks of treatment and (C) after 8 weeks of treatment.
![Figure 1. Assessment of the left elbow psoriatic lesion treated with MTX microemulsion formulation only along the treatment course for patient 1: (A) before treatment, (B) after 3 weeks of treatment and (C) after 8 weeks of treatment.](/cms/asset/e6e02ceb-83d7-4672-98f2-c313810d31a8/ianb_a_1440236_f0001_c.jpg)
Figure 2. Assessment of the right elbow psoriatic lesion treated with MTX microemulsion formulation/fractional erbium:YAG laser along the treatment course for patient 1: (A) before treatment, (B) after 3 weeks of treatment and (C) after 8 weeks of treatment.
![Figure 2. Assessment of the right elbow psoriatic lesion treated with MTX microemulsion formulation/fractional erbium:YAG laser along the treatment course for patient 1: (A) before treatment, (B) after 3 weeks of treatment and (C) after 8 weeks of treatment.](/cms/asset/ed3a1696-b216-404e-8648-38145e54559c/ianb_a_1440236_f0002_c.jpg)
Figure 3. Assessment of the left knee psoriatic lesion treated with MTX microemulsion formulation only along the treatment course for patient 2: (A) before treatment, (B) after 3 weeks of treatment and (C) after 8 weeks of treatment.
![Figure 3. Assessment of the left knee psoriatic lesion treated with MTX microemulsion formulation only along the treatment course for patient 2: (A) before treatment, (B) after 3 weeks of treatment and (C) after 8 weeks of treatment.](/cms/asset/4427f25e-62d4-490a-8355-c58796dbeea2/ianb_a_1440236_f0003_c.jpg)
Figure 4. Assessment of the right knee psoriatic lesion treated with MTX microemulsion formulation/fractional erbium:YAG laser along the treatment course for patient 2: (A) before treatment, (B) after 3 weeks of treatment and (C) after 8 weeks of treatment.
![Figure 4. Assessment of the right knee psoriatic lesion treated with MTX microemulsion formulation/fractional erbium:YAG laser along the treatment course for patient 2: (A) before treatment, (B) after 3 weeks of treatment and (C) after 8 weeks of treatment.](/cms/asset/6726a91a-fb92-45dd-a545-6df2ae0660ef/ianb_a_1440236_f0004_c.jpg)
Table 2. TES score of psoriatic plaques before and after 3 and 8 weeks of the treatment.
Figure 5. Patient with psoriatic plaques over the right elbow before treatment with microemulsion/laser combination (A,C) and after 8 weeks of treatment (B,D), showing a decreased epidermal thickness.
![Figure 5. Patient with psoriatic plaques over the right elbow before treatment with microemulsion/laser combination (A,C) and after 8 weeks of treatment (B,D), showing a decreased epidermal thickness.](/cms/asset/cbe463b9-00d0-4bab-8c8c-b5fcff9beef7/ianb_a_1440236_f0005_c.jpg)
Table 3. Comparison between right and left psoriatic plaques regarding the percent change of TES score after 3 and 8 weeks of treatment course.